Feature Articles - BioPharm International

ADVERTISEMENT

Feature Articles

Challenges and Strategies for the Downstream Purification and Formulation of Fab Antibody Fragments

January 1, 2014

Antibody fragments pose unique challenges in recovery, purification, and formulation.

Determining Criticality—Process Parameters and Quality Attributes Part II; Design of Experiments and Data-Driven Criticality

January 1, 2014

Criticality is used as a risk-based tool to drive control strategies.

Innovation and Market Growth in Brazil

January 1, 2014

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.

Biopharmaceutical Innovation Updates and Strategies

December 19, 2013

View the business side of biopharmaceuticals: strategies to fund R&D, protect patents, and manage change.

Implementing QbD in Sterile Manufacturing

December 1, 2013

Wolfgang Weikmann of Vetter Pharma discusses the implementation of quality by design in sterile manufacturing.

Employment Outlook: Mixed Results

December 1, 2013

The employment picture brightened a bit, but biopharma employees still seek better compensation.

Comparing Protein A Resins for Monoclonal Antibody Purification

December 1, 2013

A prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.

Determining Criticality-Process Parameters and Quality Attributes Part I: Criticality as a Continuum

December 1, 2013

Criticality is used as a risk-based tool to drive control strategies.

Biotechnology Innovation and Growth in Israel

December 1, 2013

Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R'D, clinical research, and market growth.

ADVERTISEMENT

ADVERTISEMENT

Click here